or
forgot password

    • cancer clinical trials in nebraska

    • Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
    Alegant Health Cancer Center at Bergan Mercy Medical Center

    Trial Locations
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Colorectal Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Breast Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Good Samaritan Cancer Center at Good Samaritan Hospital
    Kearney, Nebraska 68848-1990
    Breast Cancer
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Nebraska Methodist Hospital

    Trial Locations
    Nebraska Methodist Hospital
    Devetten, Marcel
    Myeloid Leukemia, Chronic, Chronic-Phase
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Saint Francis Medical Center

    Trial Locations
    Saint Francis Medical Center
    Great Plains Regional Medical Center
    University of Nebraska Medical Center
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center

    Trial Locations
    Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center
    Good Samaritan Cancer Center at Good Samaritan Hospital
    Callahan Cancer Center at Great Plains Regional Medical Center
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Metastatic Cancer, Prostate Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Methodist Cancer Center
    Omaha, Nebraska 68114
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Francis Medical Center

    Trial Locations
    Saint Francis Medical Center
    Good Samaritan Hospital
    Lincoln Medical Education Foundation Cancer Resource Center
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Methodist Cancer Center at Methodist Hospital - Omaha
    Omaha, Nebraska 68114
    Fallopian Tube Cancer, Ovarian Cancer
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Omaha, Nebraska 68198-7680
    Non-Hodgkin's Lymphoma
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    NE Hematology Oncology, PC

    Trial Locations
    NE Hematology Oncology, PC
    Nebraska Methodist Hospital
    Non-Small Cell Lung Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Lincoln Medical Education Foundation Cancer Resource Center

    Trial Locations
    Lincoln Medical Education Foundation Cancer Resource Center
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Cancer Resource Center - Lincoln

    Trial Locations
    Cancer Resource Center - Lincoln
    Callahan Cancer Center at Great Plains Regional Medical Center
    CCOP - Missouri Valley Cancer Consortium
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Colorectal Cancer